4
Changes in Ownership
Inmune Bio, Inc. Filed Acc 0001213900-21-034010
Options or other derivatives
- Director acquired 19,025 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ganjei James Kelly Director | 2021-06-22 | Grant or award · Option (right to buy) | +19,025 | 19,025 | D | ||
Loading xslF345X03/ownership.xml…